{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T05:24:48Z","timestamp":1731734688456,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"DOI":"10.7759\/cureus.73734","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:55:13Z","timestamp":1731671713000},"source":"Crossref","is-referenced-by-count":0,"title":["Lung Disease in Sj\u00f6gren\u2019s Syndrome: Insights From a Reference Center\u2019s Population"],"prefix":"10.7759","author":[{"given":"Catarina","family":"Silva Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Laranjeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Sim\u00e3o de Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martinha M","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Farinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivone","family":"Valad\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2018.691","article-title":"Management of primary Sj\u00f6gren's syndrome","volume":"33","author":"Marshall LL","year":"2018","unstructured":"Marshall LL, Stevens GA. Management of primary Sj\u00f6gren's syndrome. Consult Pharm. 2018, 33:691-701. 10.4140\/TCP.n.2018.691","journal-title":"Consult Pharm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211040696","article-title":"Diagnosis and management of lung involvement in systemic lupus erythematosus and Sj\u00f6gren's syndrome: a literature review","volume":"13","author":"Depascale R","year":"2021","unstructured":"Depascale R, Del Frate G, Gasparotto M, et al.. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sj\u00f6gren's syndrome: a literature review. Ther Adv Musculoskelet Dis. 2021, 13:1759720X211040696. 10.1177\/1759720X211040696","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref3","article-title":"Interstitial lung disease in Sj\u00f6gren's syndrome: a clinical review","volume":"38","author":"Luppi F","year":"2020","unstructured":"Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfred A. Interstitial lung disease in Sj\u00f6gren's syndrome: a clinical review. Clin Exp Rheumatol. 2020, 38:291-300.","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30103","article-title":"Presentation of Sjogren syndrome as nodular pulmonary amyloidosis","volume":"14","author":"Singh H","year":"2022","unstructured":"Singh H, Patel PM, Ramanan S, Zebda H, Malik D. Presentation of Sjogren syndrome as nodular pulmonary amyloidosis. Cureus. 2022, 14:e30103. 10.7759\/cureus.30103","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski CH","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al.. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017, 69:35-45. 10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror R","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P, et al.. EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide. RMD Open. 2015, 1:e000022. 10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/s8l2n0","article-title":"Factors associated with delayed diagnosis of Sj\u00f6gren's syndrome among members of the Japanese Sj\u00f6gren's Association for Patients","volume":"39","author":"Komori K","year":"2021","unstructured":"Komori K, Komori M, Horino T, Nishiyama S, Takei M, Suganuma N. Factors associated with delayed diagnosis of Sj\u00f6gren's syndrome among members of the Japanese Sj\u00f6gren's Association for Patients. Clin Exp Rheumatol. 2021, 39:146-152. 10.55563\/clinexprheumatol\/s8l2n0","journal-title":"Clin Exp Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren's","volume":"159","author":"Lee AS","year":"2021","unstructured":"Lee AS, Scofield RH, Hammitt KM, et al.. Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren's. Chest. 2021, 159:683-698. 10.1016\/j.chest.2020.10.011","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105895","article-title":"Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"163","author":"Buvry C","year":"2020","unstructured":"Buvry C, Cassagnes L, Tekath M, et al.. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sj\u00f6gren syndrome. Respir Med. 2020, 163:105895. 10.1016\/j.rmed.2020.105895","journal-title":"Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/47a4kr","article-title":"Combined seronegativity in Sj\u00f6gren's syndrome","volume":"39","author":"Chatzis LG","year":"2021","unstructured":"Chatzis LG, Pezoulas V, Voulgari PV, et al.. Combined seronegativity in Sj\u00f6gren's syndrome. Clin Exp Rheumatol. 2021, 39:80-84. 10.55563\/clinexprheumatol\/47a4kr","journal-title":"Clin Exp Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151315","article-title":"Usefulness of IgA anti-\u03b1-fodrin antibodies in combination with rheumatoid factor and\/or antinuclear antibodies as substitute immunological criterion in Sj\u00f6gren syndrome with negative anti-SSA\/SSB antibodies","volume":"43","author":"Hern\u00e1ndez-Molina G","year":"2016","unstructured":"Hern\u00e1ndez-Molina G, Nu\u00f1ez-Alvarez C, Avila-Casado C, et al.. Usefulness of IgA anti-\u03b1-fodrin antibodies in combination with rheumatoid factor and\/or antinuclear antibodies as substitute immunological criterion in Sj\u00f6gren syndrome with negative anti-SSA\/SSB antibodies. J Rheumatol. 2016, 43:1852-1857. 10.3899\/jrheum.151315","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/vmqtz4","article-title":"Candidate autoantibodies for primary Sj\u00f6gren's syndrome: where are they now?","volume":"40","author":"He J","year":"2022","unstructured":"He J, Jiang J, Baumgart K. Candidate autoantibodies for primary Sj\u00f6gren's syndrome: where are they now?. Clin Exp Rheumatol. 2022, 40:2387-2394. 10.55563\/clinexprheumatol\/vmqtz4","journal-title":"Clin Exp Rheumatol"},{"key":"ref13","article-title":"Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sj\u00f6gren's syndrome","volume":"35","author":"Locht H","year":"2008","unstructured":"Locht H, Pelck R, Manthorpe R. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sj\u00f6gren's syndrome. J Rheumatol. 2008, 35:845-849.","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318801673","article-title":"Primary Sj\u00f6gren's syndrome","volume":"27","author":"Bowman SJ","year":"2018","unstructured":"Bowman SJ. Primary Sj\u00f6gren's syndrome. Lupus. 2018, 27:32-35. 10.1177\/0961203318801673","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2020.19132","article-title":"Characterization of a subset of patients with primary Sj\u00f6gren's syndrome initially presenting with C3 or C4 hypocomplementemia","volume":"7","author":"Jord\u00e1n-Gonz\u00e1lez P","year":"2020","unstructured":"Jord\u00e1n-Gonz\u00e1lez P, Gago-Pi\u00f1ero R, Varela-Rosario N, P\u00e9rez-R\u00edos N, Vil\u00e1 LM. Characterization of a subset of patients with primary Sj\u00f6gren's syndrome initially presenting with C3 or C4 hypocomplementemia. Eur J Rheumatol. 2020, 7:112-117. 10.5152\/eurjrheum.2020.19132","journal-title":"Eur J Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren's syndrome","volume":"29","author":"Skopouli FN","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren's syndrome. Semin Arthritis Rheum. 2000, 29:296-304. 10.1016\/s0049-0172(00)80016-5","journal-title":"Semin Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/647507","article-title":"Clinical course, prognosis, and cause of death in primary Sj\u00f6gren's syndrome","volume":"2014","author":"Horvath IF","year":"2014","unstructured":"Horvath IF, Szanto A, Papp G, Zeher M. Clinical course, prognosis, and cause of death in primary Sj\u00f6gren's syndrome. J Immunol Res. 2014, 2014:647507. 10.1155\/2014\/647507","journal-title":"J Immunol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.3353","article-title":"AB0548 interstitial lung disease (ILD) in primary Sj\u00f6gren syndrome: clinical, immunological and radiological features and outcome","volume":"73","author":"Paija X","year":"2014","unstructured":"Paija X, Bosch JA, Pallisa E, Martinez-Valle F, Ramentol M, Bujan S, Solans-Laqu\u00e9 R\r\n. AB0548 interstitial lung disease (ILD) in primary Sj\u00f6gren syndrome: clinical, immunological and radiological features and outcome. Ann Rheum Dis. 2014, 73:987. 10.1136\/annrheumdis-2014-eular.3353","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.2619","article-title":"Thu0028 interstitial lung disease in primary Sj\u00f6gren Syndrome: a Gessar Analisys","volume":"73","author":"Velez SD","year":"2014","unstructured":"Velez SD, Zazzetti F, Galv\u00e1n LS, et al.. Thu0028 interstitial lung disease in primary Sj\u00f6gren Syndrome: a Gessar Analisys. Ann Rheum Dis. 2014, 73:186. 10.1136\/annrheumdis-2014-eular.2619","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01868-5","article-title":"Interstitial lung disease in Primary Sj\u00f6gren's syndrome","volume":"22","author":"Lin W","year":"2022","unstructured":"Lin W, Xin Z, Zhang J, et al.. Interstitial lung disease in Primary Sj\u00f6gren's syndrome. BMC Pulm Med. 2022, 22:73. 10.1186\/s12890-022-01868-5","journal-title":"BMC Pulm Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201013-lung-disease-in-sjgrens-syndrome-insights-from-a-reference-centers-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:55:14Z","timestamp":1731671714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201013-lung-disease-in-sjgrens-syndrome-insights-from-a-reference-centers-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.73734","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}